How does MNOW's PS Ratio compare to its peers?

MNOW is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (0.1x).

How does MNOW's PS Ratio compare vs other companies in the CA Consumer Retailing Industry?

MNOW is good value based on its Price-To-Sales Ratio (0x) compared to the North American Consumer Retailing industry average (0.3x).

What is MNOW's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MNOW's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of MNOW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MNOW's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Mednow (TSXV:MNOW) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MNOW Stock Overview

A healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. More details

MNOW fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Earnings have declined by 59.8% per year over past 5 years

Does not have a meaningful market cap (CA$517K)

Negative shareholders equity

Shares are highly illiquid

+ 2 more risks

Mednow Inc. Competitors

Trees

NEOE:TREE

CA$1.0m

PeakBirch Commerce

CNSX:PKB

CA$249.9k

JIVA Technologies

CNSX:JIVA

CA$425.1k

CareRx

TSX:CRRX

CA$106.1m

Price History & Performance

Summary of all time highs, changes and price drops for Mednow
Historical stock prices
Current Share Price	CA$0.02
52 Week High	CA$0.70
52 Week Low	CA$0.015
Beta	-1.05
11 Month Change	0%
3 Month Change	-63.64%
1 Year Change	-91.67%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-99.58%

Recent updates

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Jun 24

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

Mar 11

Shareholder Returns

	MNOW	CA Consumer Retailing	CA Market
7D	0%	-1.0%	2.2%
1Y	-91.7%	18.7%	23.4%

Return vs Industry: MNOW underperformed the Canadian Consumer Retailing industry which returned 16% over the past year.

Return vs Market: MNOW underperformed the Canadian Market which returned 0.8% over the past year.

Price Volatility

Is MNOW's price volatile compared to industry and market?
MNOW volatility
MNOW Average Weekly Movement	n/a
Consumer Retailing Industry Average Movement	3.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: MNOW's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine MNOW's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2018	n/a	n/a	mednow.ca

Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies under the Mednow Pharmacy name located in the provinces of British Columbia and Ontario. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Mednow Inc. Fundamentals Summary

How do Mednow's earnings and revenue compare to its market cap?
MNOW fundamental statistics
Market cap	CA$517.29k
Earnings (TTM)	-CA$26.13m
Revenue (TTM)	CA$41.57m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MNOW overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MNOW income statement (TTM)
Revenue	CA$41.57m
Cost of Revenue	CA$36.67m
Gross Profit	CA$4.90m
Other Expenses	CA$31.03m
Earnings	-CA$26.13m

Last Reported Earnings

Apr 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-1.01
Gross Margin	11.78%
Net Profit Margin	-62.87%
Debt/Equity Ratio	-90.6%

How did MNOW perform over the long term?

See historical performance and comparison

This company listing is no longer active

MNOW Stock Overview

Risk Analysis

Mednow Inc. Competitors

NEOE:TREE

CA$1.0m

CNSX:PKB

CA$249.9k

CNSX:JIVA

CA$425.1k

TSX:CRRX

CA$106.1m

Price History & Performance

Recent News & Updates

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Executive Changes

Mednow Inc. announced that it has received CAD 0.85 million in funding

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Recent updates

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Executive Changes

Mednow Inc. announced that it has received CAD 0.85 million in funding

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Announces Board Member Resignations

Mednow Inc. announced that it has received CAD 0.4 million in funding

Mednow Inc. announced that it expects to receive CAD 0.4 million in funding

Third quarter 2023 earnings released: CA$0.19 loss per share (vs CA$0.26 loss in 3Q 2022)

Mednow Inc. announced that it expects to receive CAD 0.585 million in funding

Mednow Inc. has completed a Composite Units Offering in the amount of CAD 0.525262 million.

Second quarter 2023 earnings released: CA$0.20 loss per share (vs CA$0.26 loss in 2Q 2022)

Mednow Inc. Supports Expanded Scope of Practice for Ontario Pharmacists

First quarter 2023 earnings released

Mednow Inc. Expands Suite of Services

Full year 2022 earnings released: CA$1.37 loss per share (vs CA$0.49 loss in FY 2021)

Mednow Inc. Announces CEO Changes

Third quarter 2022 earnings released

Mednow Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year Ending April 30, 2022

Mednow Inc., Annual General Meeting, Jun 07, 2022

Mednow Inc. (TSXV:MNOW) completed the acquisition of Mednow East Inc. from Amir Ali Reyhany-Bozorg, Felipe Campusano and Karim Nassar and others.

Mednow Inc. Provides Earnings Guidance for the Years of 2022 and 2023

Mednow Inc. (TSXV:MNOW) completed the acquisition of Liver Care Canada Inc.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire London Pharmacare Inc. from Felipe Campusano and others for CAD 0.59 million.

Mednow Inc. (TSXV:MNOW) entered into an agreement to acquire Liver Care Canada Inc. for CAD 0.07 million.

Mednow Inc. (TSXV:MNOW) completed the acquisition of Infusicare Canada Inc. from Amir Ali Reyany-Bozorg, Felipe Campusano and others for CAD 1.9 million.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire Mednow Pharmacy Inc. from Amir Ali Reyhany-Bozorg, Karim Nassar and Felipe Campusano for CAD 0.074 million.

Mednow Inc. (TSXV:MNOW) acquired 2716725 Ontario Inc. for CAD 2 million.

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Chief Financial Officer Joshua Lebovic has left the company

Mednow Inc. Appoints Carey Lai as Director of Pharmacy Operations

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

Shareholder Returns

Price Volatility

About the Company

Mednow Inc. Fundamentals Summary

0.0x

0.0x

Earnings & Revenue